Gerresheimer AG (ETR:GXI - Get Free Report)'s share price rose 0.2% during trading on Tuesday . The stock traded as high as €104.00 ($115.56) and last traded at €103.70 ($115.22). Approximately 53,456 shares were traded during mid-day trading, a decline of 62% from the average daily volume of 140,925 shares. The stock had previously closed at €103.50 ($115.00).
Gerresheimer Stock Up 0.2 %
The stock has a market capitalization of $3.58 billion, a PE ratio of 30.96, a price-to-earnings-growth ratio of 0.82 and a beta of 0.93. The company has a current ratio of 0.87, a quick ratio of 0.40 and a debt-to-equity ratio of 79.36. The company's 50-day moving average is €97.95 and its 200 day moving average is €100.94.
About Gerresheimer
(
Get Free Report)
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Gerresheimer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gerresheimer wasn't on the list.
While Gerresheimer currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
